ABCG2 and hepatocellular carcinoma: In this study, we explored the possibility of transforming a traditional chemotherapy drug into a CSC killer via the inhibition of MDR1 and ABCG2 in HCC cells, with Huh7 and PLC/PRF/5 cells as a model.